|
||||||
"Donepezil marketed under the trade name Aricept by its developer Eisai and partner Pfizer, is a centrally acting reversible acetylcholinesterase inhibitor. Its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine. Its binding to the acetylcholinesterase can be seen at Proteopedia 1eve. It has an oral bioavailability of 100% and easily crosses the blood-brain barrier. ..." Read more about Aricept |
|
To
Rotate Molecule
-->> To
Zoom-->> Jmol
Menu --->> To view Using Chime -- PDB Structure of Aricept Molecule NOTE: YOU MUST HAVE CHIME INSTALLED |
|